Final database lock results of the phase 2 cohort of lenvatinib + pembrolizumab for progressive disease after a PD-1/PD-L1-containing therapy in metastatic clear cell renal cell carcinoma
转移性透明细胞肾细胞癌患者接受含PD-1/PD-L1抑制剂治疗后疾病进展，接受乐伐替尼联合帕博利珠单抗治疗的II期队列研究的最终数据库锁定结果
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad264
Valle, Luca F; Nickols, Nicholas G; Yamoah, Kosj; Garraway, Isla P; Maxwell, Kara N; Lynch, Julie A; Lee, Chung-Han; Yogesh Shah, Amishi; Rao, Arpit; Taylor, Matthew H; Pinto, Alvaro; Girones Sarrio, Regina; Lee Cohn, Allen; Asim Bilen, Mehmet; Gunnestad Ribe, Sara; Goksel, Musaberk; Tennøe, Øyvind Krohn; Richards, Donald; Sweis, Randy F; Heinrich, Daniel; Perini, Rodolfo; Kubiak, Peter; Huang, Jie; Motzer, Robert J
